Literature DB >> 18977584

Use of complementary and alternative medicine by Korean patients with Parkinson's disease.

Sung R Kim1, Tai Y Lee, Mi S Kim, Myoung C Lee, Sun J Chung.   

Abstract

OBJECTIVES: Many patients with Parkinson's disease (PD) often utilize complementary and alternative medicine (CAM). We aimed to survey the prevalence, spectrum of use, and factors related to utilization of CAM in patients with PD in Korea. PATIENTS AND METHODS: Between 15 December 2005 and 30 April 2006, we studied 123 patients with PD who volunteered to be interviewed using semi-structured questionnaires.
RESULTS: Ninety-four (76%) patients had used CAM. The mean cost of CAM paid by patients (out-of-pocket costs) was 102.3 US Dollars (USD) per month, while medical costs of treatment for PD paid by patients (out-of-pocket costs) averaged 72.8 USD per month. Patients using CAM sought to improve motor symptoms (57.6%), fatigue (19.6%), pain (4.3%), constipation (5.4%) or specified no single reason (13.0%). The spectrum of CAM use included oriental medicines (76.6%), traditional food (44.7%), non-prescribed drugs (31.9%), traditional therapies (7.4%), massage (7.4%) and behavioral therapy (7.4%). Factors related to current use of CAM were disease duration, degree of education, and daily levodopa equivalent dose. In a logistic regression analysis, the duration of PD was a significant factor for CAM use.
CONCLUSIONS: These results suggest that a high proportion of Korean PD patients employed CAM, associated with high costs and serious side effects in some patients.

Entities:  

Mesh:

Year:  2008        PMID: 18977584     DOI: 10.1016/j.clineuro.2008.09.011

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  19 in total

1.  Complementary and alternative medicine in Parkinson's disease patients in Korea.

Authors:  Ji-Young Kim; Beom S Jeon
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 2.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

3.  Beliefs About Use of Complementary Health Approaches for Parkinson's Disease.

Authors:  Ju Young Shin; Ryan T Pohlig; Barbara Habermann
Journal:  Holist Nurs Pract       Date:  2017 Sep/Oct       Impact factor: 1.000

4.  Feasibility of clinical hypnosis for the treatment of Parkinson's disease: a case study.

Authors:  Gary Elkins; Jim Sliwinski; Juliette Bowers; Elmyra Encarnacion
Journal:  Int J Clin Exp Hypn       Date:  2013

5.  Self-reported efficacy of cannabis and other complementary medicine modalities by Parkinson's disease patients in colorado.

Authors:  Taylor Andrew Finseth; Jessica Louise Hedeman; Robert Preston Brown; Kristina I Johnson; Matthew Sean Binder; Benzi M Kluger
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

Review 6.  Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.

Authors:  Danny Bega; Cindy Zadikoff
Journal:  J Mov Disord       Date:  2014-10-30

7.  Nationwide Survey of Patient Knowledge and Attitudes towards Human Experimentation Using Stem Cells or Bee Venom Acupuncture for Parkinson's Disease.

Authors:  Sun Ju Chung; Seong Beom Koh; Young-Su Ju; Jae Woo Kim
Journal:  J Mov Disord       Date:  2014-10-30

8.  Dietary intake and plasma levels of polyunsaturated fatty acids in early-stage Parkinson's disease.

Authors:  Dallah Yoo; Yunsook Lim; Yiseul Son; Hyunkyung Rho; Chaewon Shin; Tae-Beom Ahn
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

9.  Massage efficacy beliefs for muscle recovery from a running race.

Authors:  Albert Moraska
Journal:  Int J Ther Massage Bodywork       Date:  2013-06-03

10.  Acupuncture on GB34 activates the precentral gyrus and prefrontal cortex in Parkinson's disease.

Authors:  Sujung Yeo; Il-Hwan Choe; Maurits van den Noort; Peggy Bosch; Geon-Ho Jahng; Bruce Rosen; Sung-Hoon Kim; Sabina Lim
Journal:  BMC Complement Altern Med       Date:  2014-09-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.